Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pseudomonas aeruginosa Type IV pilin protein PilA is the primary structural subunit of Type IV pili (T4P), which are multifunctional surface appendages critical for the organism's pathogenicity (UniProt, 2024, Accession P02973). PilA polymers form the pilus fiber, which enables twitching motility—a form of surface movement powered by the rapid extension and retraction of the pili (PubMed, 2014, PMC4200673). This protein also serves as a crucial adhesin, mediating the initial attachment of the bacteria to host cell receptors, such as asialo-GM1, which is a vital step in establishing respiratory and systemic infections (PubMed, 2018, PMC6136173). Beyond motility and adhesion, PilA contributes to the formation of robust biofilms and the uptake of external DNA, facilitating environmental persistence and antibiotic resistance (PubMed, 2021, PMC8230263). Because of its exposed position on the bacterial surface and its essential role in virulence, PilA is an attractive target for the development of anti-adhesive therapies and vaccines, particularly for patients with cystic fibrosis or those prone to hospital-acquired infections (PubMed, 2015, PMC4447477).
Inhibition of pilus assembly, blocking of adhesion to host epithelial cells, and promotion of opsonophagocytosis by the immune system.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa Type IV pilin protein PilA (PilA).